Commonwealth Equity Services, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

$63.2 Billion
Q2 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 34,663 shares of ARWR stock, worth $653,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,663

Previous 33,413 3.74%

Holding current value

$653,397

Previous $956,000 5.75%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$21.87 - $28.24 $27,337 - $35,300	1,250 Added 3.74%	34,663 $901,000
Q1 2024 Apr 29, 2024	SELL	$27.21 - $39.48 $14,013 - $20,332	-515 Reduced 1.52%	33,413 $956,000
Q4 2023 Feb 06, 2024	SELL	$21.2 - $31.03 $6,656 - $9,743	-314 Reduced 0.92%	33,928 $1.04 Million
Q3 2023 Oct 23, 2023	SELL	$26.2 - $36.08 $3,877 - $5,339	-148 Reduced 0.43%	34,242 $920,000
Q2 2023 Aug 10, 2023	BUY	$25.16 - $41.38 $5,484 - $9,020	218 Added 0.64%	34,390 $1.23 Million
Q1 2023 May 11, 2023	BUY	$23.68 - $38.51 $660,695 - $1.07 Million	27,901 Added 444.92%	34,172 $867,000
Q4 2022 Feb 07, 2023	SELL	$28.0 - $40.56 $6,776 - $9,815	-242 Reduced 3.72%	6,271 $254,000
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $7,437 - $12,125	-251 Reduced 3.71%	6,513 $215,000
Q2 2022 Jul 19, 2022	BUY	$27.79 - $50.61 $31,013 - $56,480	1,116 Added 19.76%	6,764 $238,000
Q1 2022 May 04, 2022	SELL	$39.62 - $69.97 $22,226 - $39,253	-561 Reduced 9.04%	5,648 $259,000
Q4 2021 Jan 31, 2022	SELL	$58.09 - $82.51 $13,941 - $19,802	-240 Reduced 3.72%	6,209 $411,000
Q3 2021 Oct 29, 2021	SELL	$58.38 - $84.96 $261,834 - $381,045	-4,485 Reduced 41.02%	6,449 $402,000
Q2 2021 Aug 11, 2021	SELL	$62.15 - $90.32 $78,868 - $114,616	-1,269 Reduced 10.4%	10,934 $905,000
Q1 2021 May 04, 2021	SELL	$61.35 - $90.47 $2,147 - $3,166	-35 Reduced 0.29%	12,203 $809,000
Q4 2020 Feb 11, 2021	BUY	$43.82 - $85.37 $10,341 - $20,147	236 Added 1.97%	12,238 $939,000
Q3 2020 Nov 05, 2020	BUY	$33.21 - $51.27 $1,129 - $1,743	34 Added 0.28%	12,002 $516,000
Q2 2020 Aug 12, 2020	BUY	$26.12 - $43.27 $7,914 - $13,110	303 Added 2.6%	11,968 $516,000
Q1 2020 May 11, 2020	SELL	$20.56 - $63.12 $42,662 - $130,974	-2,075 Reduced 15.1%	11,665 $335,000
Q4 2019 Feb 05, 2020	BUY	$28.14 - $73.01 $86,952 - $225,600	3,090 Added 29.01%	13,740 $871,000
Q3 2019 Oct 30, 2019	BUY	$26.26 - $34.86 $26,260 - $34,860	1,000 Added 10.36%	10,650 $300,000
Q2 2019 Jul 19, 2019	SELL	$17.43 - $28.82 $19,783 - $32,710	-1,135 Reduced 10.52%	9,650 $255,000
Q1 2019 May 13, 2019	BUY	$12.05 - $20.18 $129,959 - $217,641	10,785 New	10,785 $197,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

92.3M

Call Options Held

1.33M

Put Options Held

549K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Arrowhead Pharmaceuticals, Inc. Transaction History